Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of eptinezumab for migraine prevention in patients not helped by prior preventive treatments has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• EptinezuMaB

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 3 | Status: COMPLETED | Results posted: 2022-07-22